Human Tissue Engineering Company Prellis Biologics Raises $8.7 Million Series A Round; Announces First Animal Transplant of Its 3D-Printed Tissue - BioSpace
Human Tissue Engineering Company Prellis Biologics Raises $8.7 Million Series A Round; Announces First Animal Transplant of Its 3D-Printed Tissue BioSpaceSAN FRANCISCO--(BUSINESS WIRE)-- Prellis Biologics today announced that Khosla Ventures has led an $8.7 Series A investment in the company.